Virtu KCG Holdings’s Mateon Therapeutics, Inc. MATN Stock Holding History
Bought
Maintained
Sold
Other funds holding MATN
Virtu KCG Holdings's MATN Position: Q4 2016 in Review
Virtu KCG Holdings sold out of Mateon Therapeutics, Inc. (MATN) in Q4 2016, closing a stake of 11,566 shares — an estimated $7K sold.
Virtu KCG Holdings first reported a position in MATN in Q2 2016 and held it in 2 quarters. The position peaked at $11K in Q2 2016. 1 fund tracked by Wall St. Rank holds MATN as of Q4 2016.
- Virtu KCG Holdings reported no remaining Mateon Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
- Virtu KCG Holdings sold 11,566 Mateon Therapeutics, Inc. shares in Q4 2016, an estimated $7K.
- Virtu KCG Holdings first reported a position in Mateon Therapeutics, Inc. in Q2 2016 and held it in 2 quarters.
- Virtu KCG Holdings's Mateon Therapeutics, Inc. position peaked at $11K in Q2 2016.
- 1 fund tracked by Wall St. Rank held Mateon Therapeutics, Inc. as of Q4 2016.
Based on Virtu KCG Holdings's 13F filing for Q4 2016, filed 10 Feb 2017.